Assessing workforce needs for the emerging CAR-T cell therapy industry: CAREER FEATURE

The complicated and labor-intensive manufacturing of novel cell and gene therapies requires efforts to improve workforce development programs for the nascent cell therapy industry broadly, and for cell manufacturing more specifically.

Saved in:
Bibliographic Details
Published in:Nature biotechnology 2022, Vol.40 (2), p.275-278
Main Authors: Ho, Linda D., Robbins, Hadassah L., Levine, Aaron D.
Format: Article
Language:English
Subjects:
692/1537
692/700/1538
706/648/160
706/703/66
Agriculture
Bioinformatics
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Biotechnology
Career Feature
Life Sciences
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The complicated and labor-intensive manufacturing of novel cell and gene therapies requires efforts to improve workforce development programs for the nascent cell therapy industry broadly, and for cell manufacturing more specifically.
ISSN:1087-0156
1546-1696
DOI:10.1038/s41587-022-01212-6